Recent Developments: Roche - Acquisition (December 2023): Roche acquired Carmot Therapeutics, adding dual GLP-1/GIP agonist assets to its pipeline, positioning to compete with Novo Nordisk and Eli Lilly in obesity [1]
Our roundup of the best GLP-1 tracker apps compares the top choices side by side, and our free GLP-1 tracker guide explains exactly what to log and why it matters
Semaglutide activates GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors
However, these observations have not been reported in human primary islets
SNPs talk to genes using landlines: long-range chromatin interactions link genetic risk with epigenetic patterns in Takayasu arteritis
Like all prescription medications, they carry potential risks and side effects, which is why medical supervision is essential